gliclazide and trichostatin a

gliclazide has been researched along with trichostatin a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jang, ER; Kim, W; Kim, YJ; Lee, CS; Myung, SC; Yang, JC	1

Other Studies

1 other study(ies) available for gliclazide and trichostatin a

Article	Year
18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines. European journal of pharmacology, 2010, Dec-15, Volume: 649, Issue:1-3 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA Fragmentation; Drug Synergism; Enzyme Activation; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mitochondria; Ovarian Neoplasms; Prodrugs; Tumor Suppressor Protein p53	2010

Article

Year

18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines.

European journal of pharmacology, 2010, Dec-15, Volume: 649, Issue:1-3

Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA Fragmentation; Drug Synergism; Enzyme Activation; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mitochondria; Ovarian Neoplasms; Prodrugs; Tumor Suppressor Protein p53

2010